U.S. stocks gained steam Tuesday, as oil prices inched higher. The closely watched commodity remained above $43 a barrel on reports OPEC will meet in September. Oil prices hit a two-month low last week. Valeant Pharmaceuticals (VRX) reported earnings of $1.40 a share, missing estimates of $1.48. Revenue of $2.42 billion fell short of the $2.46 billion analysts were looking for. Though shares surged some six percent, as the embattled drugmaker expects 2016 earnings of $6.60 to $7.00 a share, eclipsing estimates of $6.53. Coach (COH) shares slipped after reporting earnings of $0.45 a share, beating forecasts of $0.41. Same store sales rose two percent in North America, topping forecasts of a 1.8 percent increase. Shares of Gap (GPS) fell after same-store sales dipped four percent in July amid weakness at Banana Republic stores, while analysts had expected a one percent decline. The stock fell 3.5 percent. TheStreet's Scott Gamm reports from Wall Street.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.